{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:21:53Z","timestamp":1790169713720,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation of the Montreal Heart Institute"},{"name":"Groupement pour l\u2019Etude des Maladies M\u00e9taboliques et Syst\u00e9miques"},{"name":"French Ministry of Health, Programme Hospitalier de Recherche Clinique (PHRC)","award":["PHRC-Poitiers 2004 ; PHRC-IR 2008"],"award-info":[{"award-number":["PHRC-Poitiers 2004 ; PHRC-IR 2008"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP 133649 and 14496"],"award-info":[{"award-number":["MOP 133649 and 14496"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association Fran\u00e7aise des Diab\u00e9tiques","award":["Research Grant 2003"],"award-info":[{"award-number":["Research Grant 2003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00125-016-4066-5","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T03:15:44Z","timestamp":1470280544000},"page":"2321-2330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1128-2985","authenticated-orcid":false,"given":"Barnabas","family":"Gellen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Thorin-Trescases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Gand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Fraty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Laugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Montaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Llaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rigalleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Halimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"4066_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","volume":"124","author":"R Turner","year":"1996","unstructured":"Turner R, Cull C, Holman R (1996) United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136\u2013145","journal-title":"Ann Intern Med"},{"key":"4066_CR2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829\u2013841","journal-title":"N Engl J Med"},{"key":"4066_CR3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/dc13-1159","volume":"37","author":"CA Bannister","year":"2014","unstructured":"Bannister CA, Poole CD, Jenkins-Jones S et al (2014) External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care 37:537\u2013545","journal-title":"Diabetes Care"},{"key":"4066_CR4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","volume":"56","author":"AJ Hayes","year":"2013","unstructured":"Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM (2013) UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30\u00a0year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia 56:1925\u20131933","journal-title":"Diabetologia"},{"key":"4066_CR5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00125-010-1960-0","volume":"54","author":"S Dieren van","year":"2011","unstructured":"van Dieren S, Peelen LM, Nothlings U et al (2011) External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 54:264\u2013270","journal-title":"Diabetologia"},{"key":"4066_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2013.06.003","volume":"229","author":"AE Berezin","year":"2013","unstructured":"Berezin AE, Kremzer AA (2013) Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis 229:475\u2013481","journal-title":"Atherosclerosis"},{"key":"4066_CR7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00125-015-3535-6","volume":"58","author":"HC Looker","year":"2015","unstructured":"Looker HC, Colombo M, Agakov F et al (2015) Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes. Diabetologia 58:1363\u20131371","journal-title":"Diabetologia"},{"key":"4066_CR8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCA.0000000000000252","volume":"26","author":"D Ozturk","year":"2015","unstructured":"Ozturk D, Celik O, Satilmis S et al (2015) Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden\/structure in patients with type 2 diabetes mellitus. Coron Artery Dis 26:396\u2013401","journal-title":"Coron Artery Dis"},{"key":"4066_CR9","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00125-014-3375-9","volume":"57","author":"AH Price","year":"2014","unstructured":"Price AH, Welsh P, Weir CJ et al (2014) N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetologia 57:2505\u20132512","journal-title":"Diabetologia"},{"key":"4066_CR10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc13-2580","volume":"37","author":"PJ Saulnier","year":"2014","unstructured":"Saulnier PJ, Gand E, Ragot S et al (2014) Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care 37:1425\u20131431","journal-title":"Diabetes Care"},{"key":"4066_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-015-0225-0","volume":"14","author":"BJ Scholten von","year":"2015","unstructured":"von Scholten BJ, Reinhard H, Hansen TW et al (2015) Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes. Cardiovasc Diabetol 14:59","journal-title":"Cardiovasc Diabetol"},{"key":"4066_CR12","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2337\/dc12-1416","volume":"36","author":"B Schottker","year":"2013","unstructured":"Schottker B, Herder C, Rothenbacher D et al (2013) Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care 36:1703\u20131711","journal-title":"Diabetes Care"},{"key":"4066_CR13","doi-asserted-by":"crossref","first-page":"26523","DOI":"10.1074\/jbc.274.37.26523","volume":"274","author":"I Kim","year":"1999","unstructured":"Kim I, Moon SO, Koh KN et al (1999) Molecular cloning, expression, and characterization of angiopoietin-related protein. angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 274:26523\u201326528","journal-title":"J Biol Chem"},{"key":"4066_CR14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000201","volume":"2","author":"N Farhat","year":"2013","unstructured":"Farhat N, Thorin-Trescases N, Mamarbachi M et al (2013) Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc 2, e000201","journal-title":"J Am Heart Assoc"},{"key":"4066_CR15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","volume":"10","author":"M Tabata","year":"2009","unstructured":"Tabata M, Kadomatsu T, Fukuhara S et al (2009) Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10:178\u2013188","journal-title":"Cell Metab"},{"key":"4066_CR16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/dc12-0166","volume":"36","author":"Y Doi","year":"2013","unstructured":"Doi Y, Ninomiya T, Hirakawa Y et al (2013) Angiopoietin-like protein 2 and risk of type 2 diabetes in a general Japanese population: the Hisayama study. Diabetes Care 36:98\u2013100","journal-title":"Diabetes Care"},{"key":"4066_CR17","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/0008-5472.CAN-11-3878","volume":"72","author":"M Endo","year":"2012","unstructured":"Endo M, Nakano M, Kadomatsu T et al (2012) Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res 72:1784\u20131794","journal-title":"Cancer Res"},{"key":"4066_CR18","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2014.19","volume":"16","author":"N Thorin-Trescases","year":"2014","unstructured":"Thorin-Trescases N, Thorin E (2014) Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med 16, e17","journal-title":"Expert Rev Mol Med"},{"key":"4066_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2011.04.002","volume":"339","author":"JY Zheng","year":"2011","unstructured":"Zheng JY, Zou JJ, Wang WZ et al (2011) Tumor necrosis factor-alpha increases angiopoietin-like protein 2 gene expression by activating Foxo1 in 3T3-L1 adipocytes. Mol Cell Endocrinol 339:120\u2013129","journal-title":"Mol Cell Endocrinol"},{"key":"4066_CR20","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/ATVBAHA.112.247866","volume":"32","author":"H Tazume","year":"2012","unstructured":"Tazume H, Miyata K, Tian Z et al (2012) Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 32:1400\u20131409","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4066_CR21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3892\/etm.2013.1045","volume":"5","author":"QX Meng","year":"2013","unstructured":"Meng QX, Wen L, Chen XY, Zhong HJ (2013) Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: in vitro and in vivo evidence. Exp Ther Med 5:1631\u20131636","journal-title":"Exp Ther Med"},{"key":"4066_CR22","volume":"10","author":"CL Huang","year":"2015","unstructured":"Huang CL, Wu YW, Wu CC, Hwang JJ, Yang WS (2015) Serum angiopoietin-like protein 2 concentrations are independently associated with heart failure. PLoS One 10:e0138678","journal-title":"PLoS One"},{"key":"4066_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.arcmed.2015.05.003","volume":"46","author":"Z Wang","year":"2015","unstructured":"Wang Z, Zheng H, Chen H et al (2015) Elevated serum angiopoietin-like protein 2 in patients with acute coronary syndrome. Arch Med Res 46:257\u2013264","journal-title":"Arch Med Res"},{"key":"4066_CR24","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2337\/dc07-2079","volume":"31","author":"S Hadjadj","year":"2008","unstructured":"Hadjadj S, Fumeron F, Roussel R et al (2008) Prognostic value of the insertion\/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. Diabetes Care 31:1847\u20131852","journal-title":"Diabetes Care"},{"key":"4066_CR25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"4066_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"KA Hicks","year":"2015","unstructured":"Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 66:403\u2013469","journal-title":"J Am Coll Cardiol"},{"key":"4066_CR27","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.281.14.1291","volume":"281","author":"K Gu","year":"1999","unstructured":"Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291\u20131297","journal-title":"JAMA"},{"key":"4066_CR28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jama.2015.9536","volume":"314","author":"DM Nathan","year":"2015","unstructured":"Nathan DM (2015) Diabetes: advances in diagnosis and treatment. JAMA 314:1052\u20131062","journal-title":"JAMA"},{"key":"4066_CR29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","volume":"35","author":"TC Wong","year":"2014","unstructured":"Wong TC, Piehler KM, Kang IA et al (2014) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 35:657\u2013664","journal-title":"Eur Heart J"},{"key":"4066_CR30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720\u20131732","journal-title":"N Engl J Med"},{"key":"4066_CR31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/01.ATV.0000215951.36219.a4","volume":"26","author":"J Jager de","year":"2006","unstructured":"de Jager J, Dekker JM, Kooy A et al (2006) Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol 26:1086\u20131093","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4066_CR32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabres.2013.03.028","volume":"100","author":"Q Li","year":"2013","unstructured":"Li Q, Gong W, Yang Z et al (2013) Serum Angptl2 levels are independently associated with albuminuria in type 2 diabetes. Diabetes Res Clin Pract 100:385\u2013390","journal-title":"Diabetes Res Clin Pract"},{"key":"4066_CR33","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1253\/circj.CJ-12-1548","volume":"77","author":"T Usui","year":"2013","unstructured":"Usui T, Ninomiya T, Nagata M et al (2013) Angiopoietin-like protein 2 is associated with chronic kidney disease in a general Japanese population: the Hisayama Study. Circ J 77:2311\u20132317","journal-title":"Circ J"},{"key":"4066_CR34","volume":"10","author":"Y Sasaki","year":"2015","unstructured":"Sasaki Y, Ohta M, Desai D et al (2015) Angiopoietin like protein 2 (ANGPTL2) promotes adipose tissue macrophage and T lymphocyte accumulation and leads to insulin resistance. PLoS One 10, e0131176","journal-title":"PLoS One"},{"key":"4066_CR35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96:939\u2013949","journal-title":"Circ Res"},{"key":"4066_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MOL.0b013e32830f47cd","volume":"19","author":"J Nilsson","year":"2008","unstructured":"Nilsson J, Bengtsson E, Fredrikson GN, Bjorkbacka H (2008) Inflammation and immunity in diabetic vascular complications. Curr Opin Lipidol 19:519\u2013524","journal-title":"Curr Opin Lipidol"},{"key":"4066_CR37","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1210\/en.2010-1407","volume":"152","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Nagano M, Masumoto KH, Shigeyoshi Y, Natsume T, Hashimoto S (2011) Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes. Endocrinology 152:2558\u20132567","journal-title":"Endocrinology"},{"key":"4066_CR38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000098153","volume":"44","author":"S Hatsuda","year":"2007","unstructured":"Hatsuda S, Shoji T, Shinohara K et al (2007) Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res 44:61\u201366","journal-title":"J Vasc Res"},{"key":"4066_CR39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MOL.0000000000000290","volume":"27","author":"W Dijk","year":"2016","unstructured":"Dijk W, Kersten S (2016) Regulation of lipid metabolism by angiopoietin-like proteins. Curr Opin Lipidol 27:249\u2013256","journal-title":"Curr Opin Lipidol"},{"key":"4066_CR40","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","volume":"33","author":"MR Robciuc","year":"2013","unstructured":"Robciuc MR, Maranghi M, Lahikainen A et al (2013) Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol 33:1706\u20131713","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4066_CR41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","volume":"374","author":"FE Dewey","year":"2016","unstructured":"Dewey FE, Gusarova V, O\u2019Dushlaine C et al (2016) Inactivating variants in ANGPTL4 and risk of coronary artery disease. N Engl J Med 374:1123\u20131133","journal-title":"N Engl J Med"},{"key":"4066_CR42","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","volume":"374","author":"Myocardial Infarction G, Investigators CAEC","year":"2016","unstructured":"Myocardial Infarction G, Investigators CAEC (2016) Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease. N Engl J Med 374:1134\u20131144","journal-title":"N Engl J Med"},{"key":"4066_CR43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2013.04.008","volume":"153","author":"P Yi","year":"2013","unstructured":"Yi P, Park JS, Melton DA (2013) Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 153:747\u2013758","journal-title":"Cell"},{"key":"4066_CR44","doi-asserted-by":"crossref","first-page":"10949","DOI":"10.1038\/srep10949","volume":"5","author":"M Abu-Farha","year":"2015","unstructured":"Abu-Farha M, Abubaker J, Al-Khairi I et al (2015) Higher plasma betatrophin\/ANGPTL8 level in type 2 diabetes subjects does not correlate with blood glucose or insulin resistance. Sci Rep 5:10949","journal-title":"Sci Rep"},{"key":"4066_CR45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12933-015-0277-1","volume":"14","author":"M Abu-Farha","year":"2015","unstructured":"Abu-Farha M, Abubaker J, Noronha F et al (2015) Lack of associations between betatrophin\/ANGPTL8 level and C-peptide in type 2 diabetic subjects. Cardiovasc Diabetol 14:112","journal-title":"Cardiovasc Diabetol"},{"key":"4066_CR46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.atherosclerosis.2014.10.028","volume":"237","author":"A Muendlein","year":"2014","unstructured":"Muendlein A, Saely CH, Leiherer A et al (2014) Angiopoietin-like protein 4 significantly predicts future cardiovascular events in coronary patients. Atherosclerosis 237:632\u2013638","journal-title":"Atherosclerosis"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-016-4066-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-016-4066-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:22:43Z","timestamp":1568247763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-016-4066-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["4066"],"URL":"https:\/\/doi.org\/10.1007\/s00125-016-4066-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}